281 related articles for article (PubMed ID: 34956090)
21. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER.
Li Z; Ren H; Zhao L; Zhang X; Wang T; Sun C; Niu P; Wang W; Fei H; Guo C; Chen Y; Zhao D
Curr Oncol; 2022 Jul; 29(7):4879-4892. PubMed ID: 35877247
[TBL] [Abstract][Full Text] [Related]
22. Survival comparison of pulmonary neuroendocrine carcinoma, adenocarcinoma with neuroendocrine differentiation, and adenocarcinoma.
Tai Q; Bao Y; Song N; Hu X; Duan L
J Thorac Dis; 2024 Jan; 16(1):604-614. PubMed ID: 38410570
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of neuroendocrine acquisition and biomarker expression between neuroendocrine and usual prostatic carcinoma.
Xiao GQ; Ho G; Suen C; Hurth KM
Prostate; 2021 Jun; 81(8):469-477. PubMed ID: 33848377
[TBL] [Abstract][Full Text] [Related]
24. Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.
Pan X; Yang W; Wen Z; Li F; Tong L; Tang W
J Gynecol Oncol; 2020 Nov; 31(6):e80. PubMed ID: 33078590
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
[TBL] [Abstract][Full Text] [Related]
26. Current trend of worsening prognosis of prostate small cell carcinoma: A population-based study.
Wang J; Liu X; Wang Y; Ren G
Cancer Med; 2019 Nov; 8(15):6799-6806. PubMed ID: 31518071
[TBL] [Abstract][Full Text] [Related]
27. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database.
Zhou YW; Xia RL; Chen YY; Ma XL; Liu JY
Eur J Surg Oncol; 2021 Aug; 47(8):2108-2118. PubMed ID: 33849741
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.
Lin J; Zhao Y; Zhou Y; Tian Y; He Q; Lin J; Hao H; Zou B; Jiang L; Zhao G; Lin W; Xu Y; Li Z; Xue F; Li S; Fu W; Li Y; Xu Z; Li Y; Chen J; Zhou X; Zhu Z; Cai L; Li E; Li H; Zheng C; Li P; Huang C; Xie J
JAMA Netw Open; 2021 Jul; 4(7):e2114180. PubMed ID: 34313744
[TBL] [Abstract][Full Text] [Related]
29. Smoothened loss is a characteristic of neuroendocrine prostate cancer.
Wang L; Li H; Li Z; Li M; Tang Q; Wu C; Lu Z
Prostate; 2021 Jun; 81(9):508-520. PubMed ID: 33955576
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics of 13 neuroendocrine prostate cancer patients].
Zhang WH; Si TG; Yang XL; Yang B; Liu CF; Yu HP; Xing WG; Guo Z
Zhonghua Yi Xue Za Zhi; 2017 May; 97(17):1316-1319. PubMed ID: 28482433
[No Abstract] [Full Text] [Related]
31. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics and prognostic factors of elderly small intestine adenocarcinoma using propensity score matching analysis: a study based on SEER database.
Liu QY; Xie L; Yang XY; Yang L; Lei XL
Int J Colorectal Dis; 2022 Nov; 37(11):2397-2407. PubMed ID: 36301375
[TBL] [Abstract][Full Text] [Related]
33. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
34. Analysis of survival and prognostic factors of clear cell adenocarcinoma of the prostate: a case-control study for a rare cancer entity.
Chen S; Song W; Zhang R; Jin Y; Lu Y; Lin L; Ye L; Li T; Wei Y
Sci Rep; 2023 Jun; 13(1):10317. PubMed ID: 37365217
[TBL] [Abstract][Full Text] [Related]
35. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
[TBL] [Abstract][Full Text] [Related]
36. Platinum sensitivity in metastatic prostate cancer: does histology matter?
Humeniuk MS; Gupta RT; Healy P; McNamara M; Ramalingam S; Harrison M; George D; Zhang T; Wu Y; Armstrong AJ
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):92-99. PubMed ID: 29230006
[TBL] [Abstract][Full Text] [Related]
37. Review of Checkpoint Inhibitor Immunotherapy in Neuroendocrine Tumor of Prostate and Our Experience in 2 Cases.
Pokhrel A; Nair K; Jaswani V; Salyana M; Mooppan U; Wang JC
J Investig Med High Impact Case Rep; 2022; 10():23247096221093886. PubMed ID: 35473437
[TBL] [Abstract][Full Text] [Related]
38. Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes.
Preisser F; Chun FKH; Pompe RS; Heinze A; Salomon G; Graefen M; Huland H; Tilki D
Eur Urol; 2019 Jul; 76(1):106-114. PubMed ID: 30772034
[TBL] [Abstract][Full Text] [Related]
39. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer.
Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240308
[TBL] [Abstract][Full Text] [Related]
40. Marital status, an independent predictor for survival of gastric neuroendocrine neoplasm patients: a SEER database analysis.
Zhou YJ; Lu XF; Zheng KI; Wang QW; Chen JN; Zhang QW; Yan FR; Li XB
BMC Endocr Disord; 2020 Jul; 20(1):111. PubMed ID: 32703291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
